切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2026, Vol. 12 ›› Issue (03) : 308 -314. doi: 10.3877/cma.j.issn.2096-1537.2026.03.012

综述

特发性系统性毛细血管渗漏综合征治疗的研究进展
柏李裕年1, 何宇1, 翁利2, 焦洋1,†()   
  1. 1 100730 北京,中国医学科学院 北京协和医学院 北京协和医院全科医学科(普通内科)
    2 100730 北京,中国医学科学院 北京协和医学院 北京协和医院内科ICU
  • 收稿日期:2024-08-14 出版日期:2026-08-28
  • 通信作者: 焦洋
  • 基金资助:
    美国中华医学会基金项目(20-384)

Research progress in the treatment of idiopathic systemic capillary leak syndrome

Liyunian Bai1, Yu He1, Li Weng2, Yang Jiao1,†()   

  1. 1 Department of General Practice (General Internal Medicine), Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
    2 Department of Medical ICU, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
  • Received:2024-08-14 Published:2026-08-28
  • Corresponding author: Yang Jiao
引用本文:

柏李裕年, 何宇, 翁利, 焦洋. 特发性系统性毛细血管渗漏综合征治疗的研究进展[J/OL]. 中华重症医学电子杂志, 2026, 12(03): 308-314.

Liyunian Bai, Yu He, Li Weng, Yang Jiao. Research progress in the treatment of idiopathic systemic capillary leak syndrome[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2026, 12(03): 308-314.

特发性系统性毛细血管渗漏综合征(ISCLS)是一种潜在的致命性疾病,表现为反复发作、可能危及生命的低血容量性休克、低蛋白血症和全身水肿为主要特征,严重危害患者生命健康。尽管ISCLS的具体发病机制尚不明确,也缺乏一套标准化的治疗方案,但早期识别、支持治疗和免疫调节治疗,以及防治并发症仍是治疗的核心要点。在此基础上,推荐联合适当的药物治疗。本综述对现阶段的主要治疗方法进行总结,以期对血管渗漏性疾病的整体临床治疗具有一定的指导意义。

Idiopathic systemic capillary leak syndrome (ISCLS) is a potentially fatal disorder characterized by recurrent, potentially life-threatening hypovolemic shock, severe hemoconcentration, and hypoproteinemia, posing a serious threat to patients' health. Although the precise pathogenesis of ISCLS remains unclear, and a standardized treatment protocol is lacking, early recognition, supportive care, immunomodulatory therapy, and prevention of complications remain the cornerstone of management. On this basis, the integration of appropriate pharmacological interventions may be considered. This review summarizes current major therapeutic approaches, aiming to provide guidance for the clinical management of vascular leak diseases.

1
Malla S, Pawar T, Tharu B, et al. A rare case of idiopathic systemic capillary leak syndrome[J]. J Community Hosp Intern Med Perspect, 2022, 12(4): 107-110.
2
Eo TS, Chun KJ, Hong SJ, et al. Clinical presentation, management, and prognostic factors of idiopathic systemic capillary leak syndrome: a systematic review[J]. J Allergy Clin Immunol Pract, 2018, 6(2): 609-618.
3
Vasco J, Albuquerque F, Costa F, et al. Idiopathic systemic capillary leak syndrome: report of a pediatric case[J]. Acta Med Port, 2024, 37(11): 802-804.
4
Gómez GG, Campanario OG, Serra NP, et al. Immunoglobulin treatment in severe ovarian hyperstimulation syndrome[J]. Eur J Case Rep Intern Med, 2019, 6(10): 001253.
5
Correia RS, Dos Santos DP, Delgado M. Idiopathic systemic capillary leak syndrome: a clinical case[J]. Cureus, 2023, 15(12): e50301.
6
Xie Z, Børset M, Svéen K, et al. Markers of endothelial glycocalyx dysfunction in Clarkson disease[J]. J Transl Med, 2022, 20(1): 380.
7
Mudhol RR, Bhise R. Drug-induced capillary leak syndrome[J]. J Assoc Physicians India, 2022, 70(10): 11-12.
8
Nwadozi E, Claesson-Welsh L. Hypersensitive blood vessels in Clarkson disease[J]. J Clin Invest, 2024, 134(10): e180795.
9
Ablooglu AJ, Chen WS, Xie Z, et al. Intrinsic endothelial hyperresponsiveness to inflammatory mediators drives acute episodes in models of Clarkson disease[J]. J Clin Invest, 2024, 134(10): e169137.
10
Wu MA, Locatelli L, Cogliati C, et al. Unlocking endothelial barrier restoration: FX06 in systemic capillary leak syndrome and beyond[J]. Biomed Pharmacother, 2024, 171: 116147.
11
Ablooglu AJ, Desai A, Yoo JS, et al. A ligand-independent Tie2-activating antibody reduces vascular leakage in models of Clarkson disease[J]. Sci Adv, 2023, 9(46): eadi1394.
12
Magro CM, Mo JH, Pecker MS. Idiopathic systemic capillary leak syndrome, a unique complement and interferon mediated endotheliopathy syndrome: the role of the normal skin biopsy in establishing the diagnosis and elucidating pathogenetic mechanisms[J]. Ann Diagn Pathol, 2022, 61: 152028.
13
Druey KM, Parikh SM. Idiopathic systemic capillary leak syndrome (Clarkson disease)[J]. J Allergy Clin Immunol, 2017, 140(3): 663-670.
14
Pierce R, Ji W, Chan EC, et al. Whole-exome sequencing of adult and pediatric cohorts of the rare vascular disorder systemic capillary leak syndrome[J]. Shock, 2019, 52(2): 183-190.
15
Gao D, Zhong W, Zhang W, et al. Chronic systemic capillary leak syndrome with lymphatic capillaries involvement and MYOF mutation: case report and literature review[J]. Front Genet, 2023, 14: 1282711.
16
Shin JI, Lee KH, Lee IR, et al. Systemic capillary leak syndrome (Clarkson syndrome) in cancer patients: a systematic review[J]. J Clin Med, 2018, 7(11): 418.
17
Siddall E, Khatri M, Radhakrishnan J. Capillary leak syndrome: etiologies, pathophysiology, and management[J]. Kidney Int, 2017, 92(1): 37-46.
18
Wan XC, Lai A, Kompala T, et al. Mimicker of hereditary angioedema: idiopathic systemic capillary leak syndrome successfully treated with intravenous immunoglobulin[J]. Ann Allergy Asthma Immunol, 2017, 118(5): 631-632.
19
Asmundsson ASE, Bjorklund AR, Fisher GA. Diagnosis of systemic capillary leak syndrome in a young child treated with intravenous immunoglobulin in the acute phase[J]. J Pediatr Intensive Care, 2018, 7(2): 94-96.
20
Pecker MS, Hammudi M, Melchio R, et al. Management of acute episodes of Clarkson disease (monoclonal gammopathy-associated systemic capillary leak syndrome) with intravenous immunoglobulins[J]. Ann Intern Med Clin Cases, 2022, 1(6).
21
Baloch NU, Bikak M, Rehman A, et al. Recognition and management of idiopathic systemic capillary leak syndrome: an evidence-based review[J]. Expert Rev Cardiovasc Ther, 2018, 16(5): 331-340.
22
Wu MA, Colombo R, Podda GM, et al. Handling shock in idiopathic systemic capillary leak syndrome (Clarkson's disease): less is more[J]. Intern Emerg Med, 2019, 14(5): 723-730.
23
Bichon A, Carvelli J, Bourenne J, et al. Idiopathic systemic capillary leak syndrome: 2 cases with misleading presentation[J]. Rev Med Interne, 2021, 42(9): 660-664.
24
Hsiao SC, Wang MC, Chang H, et al. Recurrent capillary leak syndrome following bortezomib therapy in a patient with relapsed myeloma[J]. Ann Pharmacother, 2010, 44(3): 587-589.
25
Pineton de Chambrun M, Gousseff M, Mauhin W, et al. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome[J]. Am J Med, 2017, 130(10): 1219.e19-e27.
26
Dasdelen S, Grebe SO. Idiopathic systemic capillary leak syndrome (Clarkson disease): a rare cause of recurrent life-threatening edema[J]. Internist (Berl), 2018, 59(7): 725-735.
27
Lamou H, Grassmann JP, Betsch M, et al. Systemic capillary leak syndrome associated with a rare abdominal and four-limb compartment syndrome: a case report[J]. J Med Case Rep, 2014, 8: 196.
28
Ghurye RR, Khan A, Yung T, et al. Successful treatment of a patient with chronic systemic capillary leak syndrome, neutropenia and thymoma[J]. J Clin Immunol, 2020, 40(1): 240-244.
29
Inoue M, Yasue Y, Kobayashi Y, et al. Systemic capillary leak syndrome (SCLS) after receiving BNT162b2 mRNA COVID-19 (Pfizer-BioNTech) vaccine[J]. BMJ Case Rep, 2022, 15(3): e248927.
30
Massafra M, Passalacqua MI, Lupo G, et al. Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer[J]. Urol Case Rep, 2021, 34: 101461.
31
Caimi PF, Pacheco Sanchez G, Sharma A, et al. Prophylactic tocilizumab prior to anti-CD19 CAR-T cell therapy for non-Hodgkin lymphoma[J]. Front Immunol, 2021, 12: 745320.
32
Druey KM, Greipp PR. Narrative review: the systemic capillary leak syndrome[J]. Ann Intern Med, 2010, 153(2): 90-98.
33
Wang P, Chan CH, Chen HF, et al. Refractory systemic capillary leak syndrome treated with bevacizumab: a case report[J]. Angiogenesis, 2022, 25(1): 9-11.
34
Bozzini MA, Milani GP, Bianchetti MG, et al. Idiopathic systemic capillary leak syndrome (Clarkson syndrome) in childhood: systematic literature review[J]. Eur J Pediatr, 2018, 177(8): 1149-1154.
35
Lee HY, Shin J, Kim SH, et al. Idiopathic systemic capillary leak syndrome: a case report[J]. BMC Nephrol, 2023, 24(1): 72.
36
Tokura M, Niwano T, Nagasaka K. Successful treatment of Sjögren's syndrome presenting as a condition similar to chronic capillary leak syndrome using combination therapy with high-dose intravenous immunoglobulin and glucocorticoid[J]. Case Rep Rheumatol, 2019, 2019: 4865024.
37
Xie Z, Kuhns DB, Gu X, et al. Neutrophil activation in systemic capillary leak syndrome (Clarkson disease)[J]. J Cell Mol Med, 2019, 23(8): 5119-5127.
38
Yabe H, Yabe M, Koike T, et al. Rapid improvement of life-threatening capillary leak syndrome after stem cell transplantation by bevacizumab[J]. Blood, 2010, 115(13): 2723-2724.
39
Qin H, Vlaminck B, Owoyemi I, et al. Successful treatment of pembrolizumab-induced severe capillary leak syndrome and lymphatic capillary dysfunction[J]. Mayo Clin Proc Innov Qual Outcomes, 2021, 5(3): 670-674.
40
Katsube A, Ohara J, Horinishi Y, et al. A case of capillary leak syndrome and intestinal ischemia caused by rheumatoid vasculitis[J]. Cureus, 2023, 15(1): e33404.
41
Khan HR, Khan S, Srikanth A, et al. A case report of capillary leak syndrome with recurrent pericardial and pleural effusions[J]. Eur Heart J Case Rep, 2020, 4(2): 1-5.
42
Kapoor P, Greipp PT, Schaefer EW, et al. Idiopathic systemic capillary leak syndrome (Clarkson's disease): the Mayo clinic experience[J]. Mayo Clin Proc, 2010, 85(10): 905-912.
43
Staak JO, Glossmann JP, Esser JM, et al. Thalidomide for systemic capillary leak syndrome[J]. Am J Med, 2003, 115(4): 332-334.
44
Ibata S, Sato T, Takada K, et al. Isoform D of vascular endothelial growth factor in systemic capillary leak syndrome: a case report[J]. J Med Case Rep, 2016, 10: 125.
45
Vigneau C, Haymann JP, Khoury N, et al. An unusual evolution of the systemic capillary leak syndrome[J]. Nephrol Dial Transplant, 2002, 17(3): 492-494.
46
Qu Y, Tang W, Hao M, et al. A preliminary study of influences of hydroxyethyl starch combined with ulinastatin on degree of edema in newborns with capillary leak syndrome[J]. Am J Transl Res, 2021, 13(4): 2626-2634.
47
Nong WX, Lv QJ, Lu YS. Veno-venous-extracorporeal membrane oxygenation treatment for severe capillary leakage syndrome: a case report[J]. World J Clin Cases, 2021, 9(33): 10273-10278.
48
Wester M, Drasch T, Schneckenpointner R, et al. COVID-19 infection triggered idiopathic capillary leak syndrome treated with ECMELLA[J]. Heliyon, 2024, 10(14): e34693.
49
Upchurch C, Blumenberg A, Brodie D, et al. Extracorporeal membrane oxygenation use in poisoning: a narrative review with clinical recommendations[J]. Clin Toxicol (Phila), 2021, 59(10): 877-887.
50
农绍汉. 新生儿毛细血管渗漏综合征[J]. 中国当代儿科杂志, 2020, 22(10): 1056-1060.
51
Al-Zaabi F, Al-Farhan H, Al-Lawati A, et al. Idiopathic capillary leak syndrome (Clarkson's disease): first reported case in Oman[J]. Oman Med J, 2024, 39(3): e635.
52
Pineton de Chambrun M, Luyt CE, Beloncle F, et al. The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission[J]. Crit Care Med, 2017, 45(7): 1216-1223.
53
Tokutake M, Nakazawa A, Ota M. Renal replacement therapy in idiopathic systemic capillary leak syndrome: a case report[J]. Cureus, 2024, 16(2): e53982.
54
Yang C, Tsang MY, Zypchen LN, et al. Pericardial effusion and systemic capillary leak syndrome late post-SARS-CoV-2 vaccination[J]. BMJ Case Rep, 2023, 16(10): e256527.
55
Akiyama Y, Inagaki T, Morioka S, et al. Exacerbations of idiopathic systemic capillary leak syndrome following BNT162b2 mRNA COVID-19 vaccine (Pfizer-BioNTech)[J]. Intern Med, 2023, 62(13): 2013-2017.
56
Neo YN, Sobti M, Zambarakji H. Bilateral simultaneous non-arteritic ischaemic optic neuropathy: a rare complication of idiopathic systemic capillary leak syndrome (SCLS)[J]. BMJ Case Rep, 2021, 14(5): e242847.
57
Horino T, Okada D, Inotani S, et al. Denileukin diftitox-induced systemic capillary leak syndrome with acute kidney injury[J]. CEN Case Rep, 2023, 12(1): 63-67.
[1] 孔祥溢, 白裕涵, 王翔宇, 张文祥, 陈力, 伍娟, 王仲照, 方仪, 王靖. 早期乳腺癌腋窝降阶梯治疗的循证医学证据与临床决策[J/OL]. 中华乳腺病杂志(电子版), 2026, 20(05): 265-271.
[2] 蔡洁琛, 余晓宁, 谢健琦. 根尖周炎根管治疗疗效列线图预测模型的构建及效能验证[J/OL]. 中华口腔医学研究杂志(电子版), 2026, 20(05): 404-409.
[3] 方振, 商亮, 李乐平. 智能化与个体化在直肠癌微创外科的应用[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 520-523.
[4] 邢维娜, 李冬蓉, 王素芳, 朱鸿飞. 胃肠外科手术患者围手术期下肢深静脉血栓形成的风险评估与防治进展[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(06): 597-601.
[5] 冯嘉耀, 曾翔宇, 赖文杰, 赵忠祥, 唐柯, 赖洪燊, 钟碧玲, 邱晓拂. 广东省医学会泌尿外科疑难病例多学科会诊(第35期)——转移性复发性嗜铬细胞瘤[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2026, 20(05): 601-608.
[6] 何晓丽, 孙晓容, 文健, 张硕辛, 向青, 张雯. 真实世界中度普利尤单抗治疗慢性阻塞性肺疾病患者的持续性及其临床决策意义[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 773-778.
[7] 龙铭, 贺斌峰, 李德峰, 高瞻, 秦蘅, 王关嵩. ADAM33基因多态性介导哮喘气道重塑及对免疫治疗效果影响的生物信息学研究[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 786-796.
[8] 杨小钰, 田建辉, 罗斌, 杨蕴, 陆鑫熠, 任胜祥. 近10年肺癌脑转移研究现状及热点分析[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 840-848.
[9] 李兴雯, 杨丽, 王关嵩, 刘佳. 精准管理模式用于慢性阻塞性肺疾病症状群干预策略中的应用研究现状与展望[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 888-893.
[10] 周叶娟, 王永兵, 李艳. Ⅲ期不可切除非小细胞肺癌治疗新进展[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 905-909.
[11] 陈博扬, 孔垂玉, 周庆. 多系分化应激耐受细胞在组织损伤修复中的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2026, 16(05): 305-313.
[12] 《中华消化病与影像杂志(电子版)》编辑委员会. 溃疡性结肠炎患者教育临床实践专家共识[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 385-394.
[13] 张建锋, 赵泽铭, 武雪亮, 马洪庆, 王贵英. 免疫联合策略在MSS/pMMR型结直肠癌转化治疗中的探索[J/OL]. 中华临床医师杂志(电子版), 2026, 20(06): 479-486.
[14] 贾珂, 张仲瑶, 池恒, 李晓兵, 唐晓梅. 卵圆孔未闭与隐源性脑卒中的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(05): 579-584.
[15] 何承远, 徐晓, 陈琴, 吴义军. 脑膜中动脉栓塞治疗非急性硬膜下血肿的研究进展[J/OL]. 中华脑血管病杂志(电子版), 2026, 20(05): 585-589.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?